Palatin Technologies (PTN) Change in Inventory (2020 - 2023)
Palatin Technologies' (PTN) quarterly Change in Inventory came in at $2.2 million in Q4 2023, up 2155.77% YoY from $98707.0 in Q4 2022, and up 307.66% on a QoQ basis from -$1.1 million in Q3 2023.
Palatin Technologies (PTN) Change in Inventory (2020 - 2023) Analysis & Trends
Palatin Technologies (PTN) has 4 years of Change in Inventory data on file, last reported at $2.2 million in Q4 2023.
- Quarterly Change in Inventory rose 2155.77% year-over-year to $2.2 million in Q4 2023, while the trailing twelve-month figure through Sep 2024 was $2.2 million (up 400.78% YoY) and the FY2024 annual result came in at $1.2 million, up 175.85% from the prior year.
- Change in Inventory improved to $2.2 million in Q4 2023, from -$1.1 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $2.2 million in Q4 2023 to a low of -$1.1 million in Q3 2023.
- A 4-year average of $198399.4 and a median of $92601.5 in 2022 frame the typical range for Change in Inventory.
- The widest YoY moves for Change in Inventory: up 2155.77% in 2023, down 1339.65% in 2023.
- Tracing PTN's Change in Inventory over 4 years: stood at $188093.0 in 2020, then tumbled by 172.86% to -$137037.0 in 2021, then jumped by 172.03% to $98707.0 in 2022, then soared by 2155.77% to $2.2 million in 2023.
- The last three Change in Inventory figures came in at $2.2 million (Q4 2023), -$1.1 million (Q3 2023), and $104033.0 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Palatin Technologies | 40.37 Mn | 40.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 2.23 Mn |
| Dec 31, 2023 | 2.23 Mn |
| Sep 30, 2023 | -1.07 Mn |
| Sep 30, 2023 | -1.07 Mn |
| Jun 30, 2023 | 104,033.00 |
| Jun 30, 2023 | 104,033.00 |
| Mar 31, 2023 | 129,235.00 |
| Mar 31, 2023 | 129,235.00 |
| Dec 31, 2022 | 98,707.00 |
| Dec 31, 2022 | 98,707.00 |
| Sep 30, 2022 | 86,496.00 |
| Sep 30, 2022 | 86,496.00 |
| Jun 30, 2022 | 347,541.00 |
| Jun 30, 2022 | 347,541.00 |
| Mar 31, 2022 | -46,908.00 |
| Mar 31, 2022 | -46,908.00 |
| Dec 31, 2021 | -137,037.00 |
| Dec 31, 2021 | -137,037.00 |
| Sep 30, 2021 | 53,933.00 |
| Sep 30, 2021 | 53,933.00 |